Is Oncolytics Biotech Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ONCY) stock is to Buy ONCY stock.
Out of 1 analyst, 0 (0%) are recommending ONCY as a Strong Buy, 1 (100%) are recommending ONCY as a Buy, 0 (0%) are recommending ONCY as a Hold, 0 (0%) are recommending ONCY as a Sell, and 0 (0%) are recommending ONCY as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year ONCY price target, the average ONCY price target is $5.00, with the highest ONCY stock price forecast at $5.00 and the lowest ONCY stock price forecast at $5.00.
The Wall Street analyst predicted that Oncolytics Biotech's share price could reach $5.00 by Aug 19, 2027. The average Oncolytics Biotech stock price prediction forecasts a potential upside of 1,150% from the current ONCY share price of $0.40.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.